Loss of CD11b exacerbates murine complement-mediated tubulointerstitial nephritis

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Chaves, Lee Daniel ^a   Bao, Lihua ^b   Wang, Ying ^b   Chang, Anthony ^b   Haas, Mark ^c   Quigg, Richard John ^a  

^a UNIVERSITY AT BUFFALO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C3B; CYCLINE; KI 67 ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN BINDING; ANTIGEN FUNCTION; ARTICLE; CELL INFILTRATION; CELL PROLIFERATION; COMPARATIVE STUDY; COMPLEMENT ACTIVATION; COMPLEMENT SYSTEM; CONTROLLED STUDY; DISEASE EXACERBATION; IMMUNOFLUORESCENCE; INFLAMMATION; INTERSTITIAL NEPHRITIS; MACROPHAGE; MONOCYTE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, CD11B; COMPLEMENT C3B; KIDNEY TRANSPLANTATION; MICE; MONOCYTES; NEPHRITIS, INTERSTITIAL; RECEPTORS, COMPLEMENT;

EID: 84898484817     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092051     Document Type: Article

References (45)

1. Kim Y-U, Kinoshita T, Molina H, Hourcade D, Seya T, et al. (1995) Mouse complement regulatory protein Crry/p65 uses the specific mechanisms of both human decay-accelerating factor and membrane cofactor protein. J Exp Med 181: 151-159.
2. Ichida S, Yuzawa Y, Okada H, Yoshioka K, Matsuo S (1994) Localization of the complement regulatory proteins in the normal human kidney. Kidney Int 46: 89-96. (Pubitemid 24210439)
3. Li B, Sallee C, Dehoff M, Foley S, Molina H, et al. (1993) Mouse Crry/p65: Characterization of monoclonal antibodies and the tissue distribution of a functional homologue of human MCP and DAF. J Immunol 151: 4295-4305. (Pubitemid 23298763)
4. Nomura A, Nishikawa K, Yuzawa Y, Okada H, Okada N, et al. (1995) Tubulointerstitial injury induced in rats by a monoclonal antibody which inhibits function of a membrane inhibitor of complement. J Clin Invest 96: 2348-2356.
5. Thurman JM, Ljubanovic D, Edelstein CL, Gilkeson GS, Holers VM (2003) Lack of a functional alternative complement pathway ameliorates ischemic acute renal failure in mice. J Immunol 170: 1517-1523. (Pubitemid 36139523)
6. Thurman JM, Royer PA, Ljubanovic D, Dursun B, Lenderink AM, et al. (2006) Treatment with an inhibitory monoclonal antibody to mouse factor B protects mice from induction of apoptosis and renal ischemia/reperfusion injury. J Am Soc Nephrol 17: 707-715.
7. Thurman JM, Ljubanovic D, Royer PA, Kraus DM, Molina H, et al. (2006) Altered renal tubular expression of the complement inhibitor Crry permits complement activation after ischemia/reperfusion. J Clin Invest 116: 357-368. (Pubitemid 43228352)
8. Thurman JM, Lucia MS, Ljubanovic D, Holers VM (2005) Acute tubular necrosis is characterized by activation of the alternative pathway of complement. Kidney Int 67: 524-530. (Pubitemid 40139844)
9. Bao L, Wang Y, Chang A, Minto AW, Zhou J, et al. (2007) Unrestricted C3 activation occurs in Crry-deficient kidneys which rapidly leads to chronic renal failure. J Am Soc Nephrol 18: 811-822. (Pubitemid 46434498)
10. Bao L, Wang Y, Haas M, Quigg RJ (2011) Distinct roles for C3a and C5a in complement-induced tubulointerstitial injury. Kidney Int 80: 524-534.
11. Xu C, Mao D, Holers VM, Palanca B, Cheng AM, et al. (2000) A critical role for murine complement regulator Crry in fetomaternal tolerance. Science 287: 498-501.
12. Mao D, Wu X, Deppong C, Friend LD, Dolecki G, et al. (2003) Negligible role of antibodies and C5 in pregnancy loss associated exclusively with C3-dependent mechanisms through complement alternative pathway. Immunity 19: 813-822. (Pubitemid 37542302)
13. Tang T, Rosenkranz A, Assmann KM, Goodman MJ, Gutierrez-Ramos JC, et al. (1997) A role for Mac-1 (CDIIb/CD18) in immune complex-stimulated neutrophil function in vivo: Mac-1 deficiency abrogates sustained Fcgamma receptor-dependent neutrophil adhesion and complement-dependent proteinuria in acute glomerulonephritis. J Exp Med 186: 1853-1863. (Pubitemid 27524595)
14. Cunningham PN, Wang Y, Guo R, He G, Quigg RJ (2004) Role of Toll-like receptor 4 in endotoxin-induced acute renal failure. J Immunol 172: 2629-2635. (Pubitemid 38182415)
15. Alexander JJ, Chaves L, Chang A, Quigg RJ (2012) The C5a receptor has a key role in immune complex glomerulonephritis in complement factor H-deficient mice. Kidney Int 82: 961-968.
16. Geissmann F, Manz MG, Jung S, Sieweke MH, Merad M, Ley K (2010) Development of monocytes, macrophages, and dendritic cells. Science 327: 656-661.
17. Shi C, Pamer EG (2011) Monocyte recruitment during infection and inflammation. Nat Rev Immunol 11: 762-774.
18. Murray PJ, Wynn TA (2011) Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 11: 723-737.
19. Kawakami T, Lichtnekert J, Thompson LJ, Karna P, Bouabe H, et al. (2013) Resident renal mononuclear phagocytes comprise five discrete populations with distinct phenotypes and functions. J Immunol 191: 3358-3372.
20. Kruger T, Benke D, Eitner F, Lang A, Wirtz M, et al. (2004) Identification and functional characterization of dendritic cells in the healthy murine kidney and in experimental glomerulonephritis. J Am Soc Nephrol 15: 613-621. (Pubitemid 38294791)
21. Soos TJ, Sims TN, Barisoni L, Lin K, Littman DR, et al. (2006) CX3CR1+ interstitial dendritic cells form a contiguous network throughout the entire kidney. Kidney Int 70: 591-596. (Pubitemid 44141588)
22. Gottschalk C, Damuzzo V, Gotot J, Kroczek RA, Yagita H, et al. (2013) Batf3-dependent dendritic cells in the renal lymph node induce tolerance against circulating antigens. J Am Soc Nephrol 24: 543-549.
23. Lukacs-Kornek V, Burgdorf S, Diehl L, Specht S, Kornek M, et al. (2008) The kidney-renal lymph node-system contributes to cross-tolerance against innocuous circulating antigen. J Immunol 180: 706-715.
24. Nelson PJ, Rees AJ, Griffin MD, Hughes J, Kurts C, et al. (2012) The renal mononuclear phagocytic system. J Am Soc Nephrol 23: 194-203.
25. Quigg RJ, Lim A, Haas M, Alexander JJ, He C, et al. (1998) Immune complex glomerulonephritis in C4- and C3-deficient mice. Kidney Int 53: 320-330. (Pubitemid 28097849)
26. Nath KA, Hostetter MK, Hostetter TH (1985) Pathophysiology of chronic tubulo-interstitial disease in rats. Interactions of dietary acid load, ammonia, and complement component C3. J Clin Invest 76: 667-675. (Pubitemid 15023121)
27. de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM (2009) Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol 20: 2075-2084.
28. Shah SN, Abramowitz M, Hostetter TH, Melamed ML (2009) Serum bicarbonate levels and the progression of kidney disease: a cohort study. Am J Kidney Dis 54: 270-277.
29. Barbour TD, Pickering MC, Cook HT (2013) Recent insights into C3 glomerulopathy. Nephrol Dial Transplant 28: 1685-1693.
30. Funabashi K, Okada N, Matsuo S, Yamamoto T, Morgan BP, et al. (1994) Tissue distribution of complement regulatory membrane proteins in rats. Immunology 81: 444-451. (Pubitemid 24245493)
31. Naik A, Sharma S, Quigg RJ (2013) Complement regulation in renal disease models. Semin Nephrol 33: 575-585.
32. Berger M, Budhu S, Lu E, Li Y, Loike D, et al. (2002) Different G(i)-coupled chemoattractant receptors signal qualitatively different functions in human neutrophils. J Leukoc Biol 71: 798-806.
33. Jones SL, Knaus UG, Bokoch GM, Brown EJ (1998) Two signaling mechanisms for activation of alphaM beta2 avidity in polymorphonuclear neutrophils. J Biol Chem 273: 10556-10566. (Pubitemid 28227667)
34. Chen X, Yu Y, Mi LZ, Walz T, Springer TA (2012) Molecular basis for complement recognition by integrin alphaXbeta2. Proc Natl Acad Sci U S A 109: 4586-4591.
35. Lanier LL (2009) DAP10- and DAP12-associated receptors in innate immunity. Immunol Rev 227: 150-160.
36. Mocsai A, Abram CL, Jakus Z, Hu Y, Lanier LL, et al. (2006) Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs. Nat Immunol 7: 1326-1333. (Pubitemid 46111254)
37. Wang L, Gordon RA, Huynh L, Su X, Park Min KH, et al. (2010) Indirect inhibition of Toll-like receptor and type I interferon responses by ITAM-coupled receptors and integrins. Immunity 32: 518-530.
38. Han C, Jin J, Xu S, Liu H, Li N, Cao X (2010) Integrin CD11b negatively regulates TLR-triggered inflammatory responses by activating Syk and promoting degradation of MyD88 and TRIF via Cbl-b. Nat Immunol 11: 734-742.
39. Means TK, Luster AD (2010) Integrins limit the Toll. Nat Immunol 11: 691-693.
40. Davies LC, Jenkins SJ, Allen JE, Taylor PR (2013) Tissue-resident macrophages. Nat Immunol 14: 986-995.
41. Davies LC, Rosas M, Smith PJ, Fraser DJ, Jones SA, et al. (2011) A quantifiable proliferative burst of tissue macrophages restores homeostatic macrophage populations after acute inflammation. Eur J Immunol 41: 2155-2164.
42. Jenkins SJ, Ruckerl D, Cook PC, Jones LH, Finkelman FD, et al. (2011) Local macrophage proliferation, rather than recruitment from the blood, is a signature of TH2 inflammation. Science 332: 1284-1288.
43. Hashimoto D, Chow A, Noizat C, Teo P, Beasley MB, et al. (2013) Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes. Immunity 38: 792-804.
44. Davies LC, Rosas M, Jenkins SJ, Liao CT, Scurr MJ, et al. (2013) Distinct bone marrow-derived and tissue-resident macrophage lineages proliferate at key stages during inflammation. Nat Commun 4: 1886.
45. Robbins CS, Hilgendorf I, Weber GF, Theurl I, Iwamoto Y, et al. (2013) Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat Med 19: 1166-1172.